For the fourth consecutive month, the Thomson Reuters’ Post Venture Capital Index (PVCI) gained ground. At the end of November, the PVCI gain 0.68 points points to end the month at 1179.63, a 0.05 percent gain from the 1178.95 mark at the end of October.
The index value ending on Nov. 30 stands more than 213 points, or 22 percent, over the 966 point value where it started at the beginning of 2017. It’s month-ending high for the year was 1289.79 on Feb. 28.
The rise in the PVCI reflects how the Nasdaq and the S&P also gained value in November.
At the end of November, the PVCI was comprised of 323 companies. Of the stocks tracked, 189 advanced in value in the month while 134 declined.
The number of companies in the index rises and falls, depending on new issues or as the companies fold or are acquired. Also, companies remain in the PVCI for only 10 years.
A total of 42 of the advancing stocks in the index were in biotech, while 32 stocks rise in the computer software sector. Consumer-related companies saw 24 stocks gain ground during November.
The largest group of decliners was in computer software with 42, followed by biotech with 32 decliners.
Facebook, as it typically does each month, ranked as the company with top market value, as of Nov. 30, followed by Tesla and NXP Semiconductors.
The index is calculated daily and does not take into account dividends.
It began in January 1986 with an initialized index value of 100.
Download Data: PVCI as of Nov. 30, 2017
Photo of business graph with red and green arrow courtesy of vasabi/iStock/Getty Images